[{"quiz_id": "ABMS20260101_kimi-k2-thinking_p02", "question_id": "ABMS20260101_kimi-k2-thinking_p02-001", "question": "A 35-year-old man develops DRESS syndrome 3 weeks after starting phenytoin. He has fever, eosinophilia, atypical lymphocytosis, and transaminitis (AST 450 U/L). HHV-6 PCR becomes positive at day 16 of illness. What is the clinical significance of this virologic finding?", "options": ["Confirms phenytoin as the causative drug", "Indicates need for ganciclovir antiviral therapy", "Predicts higher risk of disease flare and organ damage", "Represents asymptomatic viral reactivation without prognostic value", "Suggests alternative diagnosis of acute HHV-6 infection"], "answer": "C", "answer_index": 2, "explanation": "HHV-6 reactivation at weeks 2-3 in DRESS is pathogenically linked to disease severity, predicting higher risk of relapse, end-organ damage, and prolonged course. It indicates need for more aggressive immunosuppression, not antiviral therapy, as the virus is a marker of immune dysregulation.", "generator_model": "kimi-k2-thinking", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Dermatology", "abms_specialty": "Dermatology", "abms_source": "topics_mapped", "source_label_raw": "Dermatology", "source_quiz_id": "20251205T080918850Z_kimi-k2-thinking_seed126", "source_question_id": "20251205T080918850Z_kimi-k2-thinking_seed126-010", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/kimi-k2-thinking/20251205T080918850Z_kimi-k2-thinking_seed126", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026_backup/20251205T080918850Z_kimi-k2-thinking_seed126.jsonl", "pred": "C", "model_outputs": "The answer is (C)"}, {"quiz_id": "ABMS20260101_kimi-k2-thinking_p02", "question_id": "ABMS20260101_kimi-k2-thinking_p02-002", "question": "A 58-year-old kidney transplant recipient (deceased donor, 8 months post-transplant) presents with rising creatinine from 1.2 to 2.1 mg/dL. Plasma BK virus PCR is 18,000 copies/mL. Allograft biopsy shows Banff class B BK virus nephropathy. Current immunosuppression: tacrolimus 5 mg twice daily (trough 8 ng/mL), mycophenolate mofetil 1000 mg twice daily, prednisone 5 mg daily. What is the first immunosuppression modification?", "options": ["Reduce tacrolimus dose by 50%", "Reduce mycophenolate mofetil by 50%", "Discontinue tacrolimus and switch to cyclosporine", "Discontinue mycophenolate mofetil completely", "Reduce prednisone to 2.5 mg daily"], "answer": "B", "answer_index": 1, "explanation": "For BK viremia >10,000 copies/mL with Banff class B nephropathy, first-line therapy is mycophenolate dose reduction by 50% or complete discontinuation. Tacrolimus reduction is second-line if viremia persists after 2-4 weeks. This sequence preserves tacrolimus (the cornerstone immunosuppressant) while reducing the antiproliferative agent that most impairs viral clearance. Steroids should not be reduced initially.", "generator_model": "kimi-k2-thinking", "seed": 133, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Urology", "abms_specialty": "Urology", "abms_source": "target_topic", "source_label_raw": "Urology", "source_quiz_id": "20251225T234023630Z_kimi-k2-thinking_seed133", "source_question_id": "20251225T234023630Z_kimi-k2-thinking_seed133-005", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/kimi-k2-thinking/20251225T234023630Z_kimi-k2-thinking_seed133", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251225T234023630Z_kimi-k2-thinking_seed133.jsonl", "pred": "B", "model_outputs": "The answer is (B)"}, {"quiz_id": "ABMS20260101_kimi-k2-thinking_p02", "question_id": "ABMS20260101_kimi-k2-thinking_p02-003", "question": "A 55-year-old man has left vocal fold paralysis 6 months after thyroidectomy, with persistent aspiration and breathy voice. EMG shows absent motor unit potentials. What is the optimal injection laryngoplasty material?", "options": ["A) Hyaluronic acid gel for temporary medialization", "B) Calcium hydroxylapatite paste for permanent augmentation", "C) Autologous fat injection for long-term volume restoration", "D) Gelfoam paste for temporary 3-month effect", "E) Polydimethylsiloxane for permanent irreversible medialization"], "answer": "B", "answer_index": 1, "explanation": "For permanent vocal fold paralysis with absent EMG potentials, calcium hydroxylapatite provides durable medialization without migration. Its high viscosity prevents particle dispersion, and it integrates into tissue without foreign body reaction. Hyaluronic acid and Gelfoam are temporary (<6 months) and unsuitable for permanent paralysis. Autologous fat has unpredictable resorption (50-80% at 1 year), and polydimethylsiloxane risks granuloma formation and airway compromise if overinjected.", "generator_model": "kimi-k2-thinking", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Otolaryngology", "abms_specialty": "Otolaryngology", "abms_source": "target_topic", "source_label_raw": "Otolaryngology", "source_quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed130", "source_question_id": "20251221T010349114Z_kimi-k2-thinking_seed130-016", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/kimi-k2-thinking/20251221T010349114Z_kimi-k2-thinking_seed130", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251221T010349114Z_kimi-k2-thinking_seed130.jsonl", "pred": "E", "model_outputs": "The answer is (E)"}, {"quiz_id": "ABMS20260101_kimi-k2-thinking_p02", "question_id": "ABMS20260101_kimi-k2-thinking_p02-004", "question": "A 45-year-old man with T6 complete spinal cord injury has a stage 4 sacral pressure ulcer with positive probe-to-bone test and MRI showing marrow edema limited to cortex. He has been on antibiotics for 4 weeks with minimal improvement. What is definitive management?", "options": ["A) Continue suppressive antibiotics indefinitely with wound care", "B) Surgical debridement to bone with burr drilling, VAC therapy, then gluteal myocutaneous flap", "C) Radical debridement with partial sacrectomy and omental flap", "D) Transcutaneous bone biopsy and targeted IV antibiotics for 12 weeks", "E) Osteomyelitis excision with free latissimus dorsi muscle flap"], "answer": "B", "answer_index": 1, "explanation": "Stage 4 sacral ulcer with cortical osteomyelitis requires surgical debridement with burr drilling of exposed bone to bleeding cortex, followed by VAC therapy to prepare granulation tissue, then gluteal myocutaneous flap coverage. This achieves 85% healing rates. Partial sacrectomy is reserved for medullary involvement. Suppressive antibiotics alone fail in 70% of cases, and free flaps are unnecessary when local muscle is available and viable.", "generator_model": "kimi-k2-thinking", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Physical Medicine and Rehabilitation", "abms_specialty": "Physical Medicine and Rehabilitation", "abms_source": "target_topic", "source_label_raw": "Physical Medicine and Rehabilitation", "source_quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed130", "source_question_id": "20251221T010349114Z_kimi-k2-thinking_seed130-017", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/kimi-k2-thinking/20251221T010349114Z_kimi-k2-thinking_seed130", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251221T010349114Z_kimi-k2-thinking_seed130.jsonl", "pred": "B", "model_outputs": "B\nThe answer is (B)"}, {"quiz_id": "ABMS20260101_kimi-k2-thinking_p02", "question_id": "ABMS20260101_kimi-k2-thinking_p02-005", "question": "A 71-year-old man with history of scalp radiation for basal cell carcinoma 20 years ago develops a 5 cm recurrent tumor with 2 cm calvarial erosion. After oncologic resection, there is a full-thickness calvarial defect with dural exposure. What is the optimal reconstruction?", "options": ["A) Latissimus dorsi myocutaneous free flap with split-thickness skin graft", "B) Omental free flap with vascularized bone graft", "C) Pericranial flap rotation with split calvarial graft", "D) Latissimus dorsi muscle-only free flap with skin graft and delayed cranioplasty", "E) Anterolateral thigh fasciocutaneous flap with titanium mesh"], "answer": "D", "answer_index": 3, "explanation": "In irradiated scalp defects with calvarial exposure, muscle-only free flaps (latissimus dorsi) provide robust vascularity to compromised beds while allowing secondary skin grafting. The muscle conforms better to calvarial contours than fasciocutaneous flaps, and delayed cranioplasty after soft tissue healing reduces hardware exposure risk. Myocutaneous flaps are too bulky, and local pericranial flaps have unreliable vascularity in previously irradiated fields.", "generator_model": "kimi-k2-thinking", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Plastic Surgery", "abms_specialty": "Plastic Surgery", "abms_source": "target_topic", "source_label_raw": "Plastic Surgery", "source_quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed130", "source_question_id": "20251221T010349114Z_kimi-k2-thinking_seed130-008", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/kimi-k2-thinking/20251221T010349114Z_kimi-k2-thinking_seed130", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251221T010349114Z_kimi-k2-thinking_seed130.jsonl", "pred": "C", "model_outputs": "The answer is (C)"}, {"quiz_id": "ABMS20260101_kimi-k2-thinking_p02", "question_id": "ABMS20260101_kimi-k2-thinking_p02-006", "question": "A 28-year-old woman presents with progressive myelopathy over 6 months. MRI shows a holocord enhancing lesion from C2 to T9 with cystic components. Intraoperative neuromonitoring shows 60% amplitude reduction in motor evoked potentials after initial tumor debulking. What is the next surgical decision?", "options": ["A) Continue aggressive debulking despite signal changes", "B) Halt resection, perform duraplasty, and plan staged resection", "C) Switch to ultrasonic aspiration for gentler tumor removal", "D) Administer high-dose steroids and continue resection", "E) Perform en bloc resection of involved cord segments"], "answer": "B", "answer_index": 1, "explanation": "For holocord ependymoma, intraoperative neuromonitoring with >50% MEP amplitude reduction mandates immediate cessation of resection to prevent permanent neurologic deficit. Staged resection after allowing neural recovery (typically 3-6 months) achieves maximal safe cytoreduction. Continuing despite signal loss causes paraplegia, while en bloc resection is contraindicated in holocord lesions. Ultrasonic aspiration still transmits vibratory injury to compressed neural tissue.", "generator_model": "kimi-k2-thinking", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Neurological Surgery", "abms_specialty": "Neurological Surgery", "abms_source": "target_topic", "source_label_raw": "Neurological Surgery", "source_quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed130", "source_question_id": "20251221T010349114Z_kimi-k2-thinking_seed130-009", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/kimi-k2-thinking/20251221T010349114Z_kimi-k2-thinking_seed130", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251221T010349114Z_kimi-k2-thinking_seed130.jsonl", "pred": "B", "model_outputs": "The answer is (B)"}, {"quiz_id": "ABMS20260101_kimi-k2-thinking_p02", "question_id": "ABMS20260101_kimi-k2-thinking_p02-007", "question": "A 62-year-old man with T2N0M0 glottic carcinoma involving the anterior commissure is scheduled for definitive radiation therapy. He has good performance status and no comorbidities. What is the optimal fractionation scheme to maximize local control?", "options": ["A) 70 Gy in 35 fractions over 7 weeks with concurrent cisplatin", "B) 66 Gy in 33 fractions over 6.5 weeks with concurrent cetuximab", "C) 72 Gy in 42 fractions using concomitant boost over 6 weeks", "D) 60 Gy in 30 fractions over 6 weeks with hyperfractionation", "E) 50 Gy in 20 fractions over 4 weeks with hypofractionation"], "answer": "C", "answer_index": 2, "explanation": "For T2 glottic cancer with anterior commissure involvement, altered fractionation with concomitant boost (72 Gy/42 fractions/6 weeks) improves 5-year local control to 85% versus 70% with standard fractionation, without increasing late toxicity. The anterior commissure is a sanctuary site with poor vascularity, requiring higher biologically effective dose. Concurrent chemotherapy is not indicated for T2 disease and increases mucositis. Hypofractionation is reserved for early T1 lesions without commissure involvement.", "generator_model": "kimi-k2-thinking", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Radiation Oncology", "abms_specialty": "Radiation Oncology", "abms_source": "target_topic", "source_label_raw": "Radiation Oncology", "source_quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed130", "source_question_id": "20251221T010349114Z_kimi-k2-thinking_seed130-020", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/kimi-k2-thinking/20251221T010349114Z_kimi-k2-thinking_seed130", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251221T010349114Z_kimi-k2-thinking_seed130.jsonl", "pred": "D", "model_outputs": "The answer is (D)"}, {"quiz_id": "ABMS20260101_kimi-k2-thinking_p02", "question_id": "ABMS20260101_kimi-k2-thinking_p02-008", "question": "A 68-year-old man is 18 days post-Ivor Lewis esophagectomy with gastric conduit reconstruction for stage III esophageal adenocarcinoma. He develops sudden onset cough with swallowing, respiratory distress, and sepsis. Chest CT demonstrates a 5 mm fistula between the gastric conduit and right mainstem bronchus at the level of the carina, with surrounding mediastinal air and fluid. Bronchoscopy confirms the fistula with conduit mucosa visible. What is the definitive management?", "options": ["A) Endoscopic placement of overlapping esophageal and airway stents", "B) Emergency right thoracotomy with fistula repair using intercostal muscle flap and conduit resection with cervical esophagostomy", "C) NPO status, total parenteral nutrition, and broad-spectrum antibiotics for 6 weeks", "D) Bronchoscopic application of fibrin glue and continued enteral feeding via jejunostomy", "E) Cervical esophagostomy and conduit abandonment without fistula repair"], "answer": "B", "answer_index": 1, "explanation": "Early postoperative tracheobronchial-gastric conduit fistula requires urgent surgical repair with viable muscle flap reinforcement; conduit ischemia at the anastomotic line necessitates conduit resection and delayed reconstruction. Endoscopic stenting has >80% failure rate in this setting due to conduit tension and ongoing contamination.", "generator_model": "kimi-k2-thinking", "seed": 131, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Thoracic Surgery", "abms_specialty": "Thoracic Surgery", "abms_source": "target_topic", "source_label_raw": "Thoracic Surgery", "source_quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed131", "source_question_id": "20251221T010349114Z_kimi-k2-thinking_seed131-001", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/kimi-k2-thinking/20251221T010349114Z_kimi-k2-thinking_seed131", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251221T010349114Z_kimi-k2-thinking_seed131.jsonl", "pred": "B", "model_outputs": "The answer is (B)"}, {"quiz_id": "ABMS20260101_kimi-k2-thinking_p02", "question_id": "ABMS20260101_kimi-k2-thinking_p02-009", "question": "A 72-year-old man has a 5.5 cm infrarenal abdominal aortic aneurysm with a thick circumferential rind of periaortic inflammation, bilateral ureteral obstruction with hydronephrosis, and elevated ESR (85 mm/hr) and CRP (120 mg/L). What is the optimal management sequence?", "options": ["A) Immediate open surgical repair with prednisone 1 mg/kg", "B) Endovascular aortic repair (EVAR) then prednisone 1 mg/kg", "C) Prednisone 40 mg daily for 6 weeks then open surgical repair", "D) Prednisone 40 mg daily for 6 weeks then EVAR", "E) Prednisone alone without aortic repair"], "answer": "D", "answer_index": 3, "explanation": "Inflammatory AAA requires initial steroid therapy to reduce periaortic inflammation and relieve ureteral obstruction. Delayed EVAR is preferred over open repair due to severe periaortic inflammation that increases surgical morbidity. Steroids alone risk aneurysm rupture.", "generator_model": "kimi-k2-thinking", "seed": 131, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Vascular Surgery", "abms_specialty": "Vascular Surgery", "abms_source": "target_topic", "source_label_raw": "Vascular Surgery", "source_quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed131", "source_question_id": "20251221T010349114Z_kimi-k2-thinking_seed131-012", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/kimi-k2-thinking/20251221T010349114Z_kimi-k2-thinking_seed131", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251221T010349114Z_kimi-k2-thinking_seed131.jsonl", "pred": "C", "model_outputs": "The answer is (C)"}, {"quiz_id": "ABMS20260101_kimi-k2-thinking_p02", "question_id": "ABMS20260101_kimi-k2-thinking_p02-010", "question": "An 18-year-old male with genetically confirmed Danon disease (LAMP2 mutation) presents with severe hypertrophic cardiomyopathy (septal thickness 28 mm), ventricular pre-excitation (WPW pattern on ECG), and recurrent syncope. Electrophysiology study identifies three distinct accessory pathways. Despite maximal medical therapy, he continues to have pre-excited atrial fibrillation. What is the most appropriate next management step?", "options": ["A) Initiate flecainide therapy", "B) Perform catheter ablation of all accessory pathways", "C) Increase beta-blocker dosage", "D) Evaluate for heart transplantation", "E) Implant a dual-chamber pacemaker"], "answer": "D", "answer_index": 3, "explanation": "Danon disease causes rapidly progressive HCM, multiple accessory pathways, and skeletal myopathy with poor prognosis. Catheter ablation is often unsuccessful due to rapid pathway recurrence and progressive myocardial involvement. Beta-blockers and verapamil are contraindicated in WPW with pre-excited AF. Flecainide may transiently suppress pathways but doesn't alter disease course. Early heart transplant evaluation is recommended given the high mortality from arrhythmias and heart failure.", "generator_model": "kimi-k2-thinking", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Cardiovascular", "abms_specialty": "Cardiovascular", "abms_source": "topics_mapped", "source_label_raw": "cardiology", "source_quiz_id": "20251205T080918850Z_kimi-k2-thinking_seed124", "source_question_id": "20251205T080918850Z_kimi-k2-thinking_seed124-003", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/kimi-k2-thinking/20251205T080918850Z_kimi-k2-thinking_seed124", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026_backup/20251205T080918850Z_kimi-k2-thinking_seed124.jsonl", "pred": "B", "model_outputs": "The answer is (B)"}]